H1B Report
Side-by-side comparison

Cedars-Sinai Medical Center vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Cedars-Sinai Medical Center
CARank #FEIN 95-1644600
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricCedars-Sinai Medical CenterDeloitte Consulting LLP
Total filings96280,813
Certified %88.77%98.23%
Denied %1.46%1.09%
Withdrawn %1.98%0.61%
Cert-withdrawn %7.80%0.07%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateCAPA

Outcomes — Cedars-Sinai Medical Center

DOL case-status mix.

Outcome breakdown: Certified 88.8%, Cert-withdrawn 7.8%, Withdrawn 2.0%, Denied 1.5%
Outcome breakdown
OutcomeShare
Certified88.8%
Cert-withdrawn7.8%
Withdrawn2.0%
Denied1.5%
Certified88.8%
Cert-withdrawn7.8%
Withdrawn2.0%
Denied1.5%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Cedars-Sinai Medical Center
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201052
FY201163
FY201258
FY201368
FY201454
FY201565
FY201663
FY201749
FY201862
FY201981
FY20208
FY202113
FY20228
FY202325
FY202493
FY2025106
FY202694
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612

Top 5 occupations — Cedars-Sinai Medical Center

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.